UA81573C2 - Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients - Google Patents
Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patientsInfo
- Publication number
- UA81573C2 UA81573C2 UAA200609697A UAA200609697A UA81573C2 UA 81573 C2 UA81573 C2 UA 81573C2 UA A200609697 A UAA200609697 A UA A200609697A UA A200609697 A UAA200609697 A UA A200609697A UA 81573 C2 UA81573 C2 UA 81573C2
- Authority
- UA
- Ukraine
- Prior art keywords
- agomelatine
- sleep disorders
- medicaments
- preparation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0509207A FR2890562B1 (fr) | 2005-09-09 | 2005-09-09 | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA81573C2 true UA81573C2 (en) | 2008-01-10 |
Family
ID=36200255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200609697A UA81573C2 (en) | 2005-09-09 | 2006-09-08 | Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20070060655A1 (es) |
| EP (2) | EP1762237A1 (es) |
| JP (1) | JP2007077148A (es) |
| KR (2) | KR20070029608A (es) |
| CN (1) | CN1927193B (es) |
| AP (1) | AP2008004379A0 (es) |
| AR (1) | AR056063A1 (es) |
| AU (1) | AU2006209372A1 (es) |
| BR (1) | BRPI0603762A (es) |
| CA (1) | CA2558762A1 (es) |
| EA (1) | EA014288B1 (es) |
| FR (1) | FR2890562B1 (es) |
| GE (1) | GEP20094602B (es) |
| GT (1) | GT200600409A (es) |
| MA (1) | MA28506B1 (es) |
| MX (1) | MXPA06010233A (es) |
| NO (1) | NO20064050L (es) |
| NZ (1) | NZ549726A (es) |
| PE (1) | PE20070333A1 (es) |
| SG (1) | SG146451A1 (es) |
| TW (1) | TW200800148A (es) |
| UA (1) | UA81573C2 (es) |
| UY (1) | UY29777A1 (es) |
| WO (1) | WO2007028905A1 (es) |
| ZA (1) | ZA200607531B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2918372B1 (fr) * | 2007-07-02 | 2009-08-28 | Servier Lab | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2918370B1 (fr) * | 2007-07-02 | 2009-08-28 | Servier Lab | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CN102190595A (zh) * | 2010-03-17 | 2011-09-21 | 上海医药工业研究院 | 阿戈美拉汀溴化氢水合物及其制备方法 |
| CN102190594A (zh) * | 2010-03-17 | 2011-09-21 | 上海医药工业研究院 | 阿戈美拉汀氯化氢水合物及其制备方法 |
| CN101991559B (zh) * | 2010-11-25 | 2012-04-18 | 天津市汉康医药生物技术有限公司 | 一种稳定的阿戈美拉汀胶囊药物组合物 |
| FR2978916B1 (fr) * | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
| WO2013119605A1 (en) * | 2012-02-07 | 2013-08-15 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Promoting sleep using at1 receptor blockers |
| CN102552211B (zh) * | 2012-02-16 | 2013-07-17 | 福建广生堂药业股份有限公司 | 一种阿戈美拉汀的制剂组合物及其制备方法 |
| EP2810656B1 (en) | 2013-06-06 | 2017-08-02 | Zentiva, a.s. | Agomelatine formulations comprising agomelatine in the form of co-crystals |
| EP2810647A1 (en) | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid |
| EP2856934A1 (en) * | 2013-10-04 | 2015-04-08 | Les Laboratoires Servier | Biomarkers for the prediction of long term remission in depression |
| CN103655499B (zh) * | 2013-12-23 | 2015-07-22 | 天津泰普药品科技发展有限公司 | 一种稳定的晶x型阿戈美拉汀片剂及其制备方法 |
| CN103690499B (zh) * | 2013-12-23 | 2015-05-06 | 天津泰普药品科技发展有限公司 | 一种稳定的晶i型阿戈美拉汀片剂及其制备方法 |
| CN104523639B (zh) * | 2014-12-11 | 2017-03-22 | 扬子江药业集团四川海蓉药业有限公司 | 一种阿戈美拉汀片剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2834890B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'agomelatine |
| WO2005063297A2 (en) * | 2003-12-24 | 2005-07-14 | Sepracor Inc. | Melatonin combination therapy for improving sleep quality |
| FR2866335B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
| US7635721B2 (en) * | 2005-08-03 | 2009-12-22 | Les Laboratoires Servier | Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| US7645905B2 (en) * | 2005-08-03 | 2010-01-12 | Les Laboratoires Servier | Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| US7358395B2 (en) * | 2005-08-03 | 2008-04-15 | Les Laboratories Servier | Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
-
2005
- 2005-09-09 FR FR0509207A patent/FR2890562B1/fr not_active Expired - Fee Related
-
2006
- 2006-08-22 MA MA29282A patent/MA28506B1/fr unknown
- 2006-08-29 CN CN2006101265880A patent/CN1927193B/zh not_active Expired - Fee Related
- 2006-08-31 SG SG200605975-2A patent/SG146451A1/en unknown
- 2006-08-31 UY UY29777A patent/UY29777A1/es unknown
- 2006-09-04 PE PE2006001068A patent/PE20070333A1/es not_active Application Discontinuation
- 2006-09-06 BR BRPI0603762-3A patent/BRPI0603762A/pt not_active IP Right Cessation
- 2006-09-07 GE GEAP20069611A patent/GEP20094602B/en unknown
- 2006-09-07 NZ NZ549726A patent/NZ549726A/en not_active IP Right Cessation
- 2006-09-07 US US11/517,520 patent/US20070060655A1/en not_active Abandoned
- 2006-09-08 GT GT200600409A patent/GT200600409A/es unknown
- 2006-09-08 ZA ZA200607531A patent/ZA200607531B/xx unknown
- 2006-09-08 AU AU2006209372A patent/AU2006209372A1/en not_active Abandoned
- 2006-09-08 EA EA200601449A patent/EA014288B1/ru not_active IP Right Cessation
- 2006-09-08 UA UAA200609697A patent/UA81573C2/xx unknown
- 2006-09-08 TW TW095133158A patent/TW200800148A/zh unknown
- 2006-09-08 WO PCT/FR2006/002068 patent/WO2007028905A1/fr not_active Ceased
- 2006-09-08 AR ARP060103908A patent/AR056063A1/es not_active Application Discontinuation
- 2006-09-08 MX MXPA06010233A patent/MXPA06010233A/es not_active Application Discontinuation
- 2006-09-08 CA CA002558762A patent/CA2558762A1/fr not_active Abandoned
- 2006-09-08 EP EP06291422A patent/EP1762237A1/fr not_active Ceased
- 2006-09-08 AP AP2008004379A patent/AP2008004379A0/xx unknown
- 2006-09-08 NO NO20064050A patent/NO20064050L/no not_active Application Discontinuation
- 2006-09-08 EP EP10011610A patent/EP2295050A1/fr not_active Withdrawn
- 2006-09-11 JP JP2006245010A patent/JP2007077148A/ja active Pending
- 2006-09-11 KR KR1020060087713A patent/KR20070029608A/ko not_active Ceased
-
2008
- 2008-10-31 KR KR1020080107661A patent/KR20080103043A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AP2008004379A0 (en) | 2008-04-30 |
| PE20070333A1 (es) | 2007-06-02 |
| FR2890562B1 (fr) | 2012-10-12 |
| GT200600409A (es) | 2007-04-30 |
| UY29777A1 (es) | 2006-10-31 |
| KR20080103043A (ko) | 2008-11-26 |
| JP2007077148A (ja) | 2007-03-29 |
| EA014288B1 (ru) | 2010-10-29 |
| EP1762237A1 (fr) | 2007-03-14 |
| EP2295050A1 (fr) | 2011-03-16 |
| NO20064050L (no) | 2007-03-12 |
| MA28506B1 (fr) | 2007-04-03 |
| WO2007028905A1 (fr) | 2007-03-15 |
| CN1927193A (zh) | 2007-03-14 |
| EA200601449A1 (ru) | 2007-04-27 |
| KR20070029608A (ko) | 2007-03-14 |
| FR2890562A1 (fr) | 2007-03-16 |
| CN1927193B (zh) | 2011-01-05 |
| HK1100481A1 (en) | 2007-09-21 |
| MXPA06010233A (es) | 2007-03-08 |
| TW200800148A (en) | 2008-01-01 |
| US20070060655A1 (en) | 2007-03-15 |
| ZA200607531B (en) | 2008-05-28 |
| AR056063A1 (es) | 2007-09-19 |
| NZ549726A (en) | 2008-03-28 |
| AU2006209372A1 (en) | 2007-03-29 |
| SG146451A1 (en) | 2008-10-30 |
| GEP20094602B (en) | 2009-02-10 |
| BRPI0603762A (pt) | 2007-05-15 |
| CA2558762A1 (fr) | 2007-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
| CL2008003363A1 (es) | Uso de 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina y sus sales farmaceuticamente aceptables para tratar depresion severa, ansiedad, abuso o dolor cronico, en pacientes que han recibido medicacion con anterioridad y que han abandonado o reducido a eventos adversos relacionados con el sueño o la actividad sexual. | |
| MX2011013902A (es) | Tratamiento de esclerosis multiple con laquinimod. | |
| UA81573C2 (en) | Use of agomelatine for the preparation of medicaments for the treatment of sleep disorders in depressed patients | |
| IL198184A0 (en) | Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue | |
| YU30004A (sh) | Upotreba flibanserina u lečenju seksualnih poremećaja | |
| SG166820A1 (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
| EA200700574A3 (ru) | Применение агомелатина в получении лекарственных средств, предназначенных для лечения генерализированного тревожного расстройства | |
| PL2081910T3 (pl) | Nowe związki | |
| PL2111868T3 (pl) | Zastosowanie ludzkiej albuminy do wytwarzania leku do leczenia pacjentów cierpiących na zaburzenia funkcji poznawczych | |
| SE0400184D0 (sv) | New therapeutical use | |
| TW200719882A (en) | Treatment of connective tissue diseases of the skin | |
| MX2008002456A (es) | Uso de ambroxol para el tratamiento de infecciones por rinovirus. | |
| IL186373A0 (en) | Use of agomelatine for obtaining medicaments used for treating bipolar disorders | |
| MY145925A (en) | Use of agomelatine to obtain medication aimed at treating periventricular leukomalacia | |
| WO2009025091A1 (ja) | 線維筋痛症治療用医薬組成物 | |
| SI1824472T1 (sl) | Uporaba acetil-l-karnitina za zdravljenje fibromialgiäśnega sindroma | |
| PL356378A1 (en) | Medicinal product for metal therapy to be attached to skin, foot cover, sock and elastic bandage |